Enpro Announces Date for Second Quarter 2025 Earnings Release and Conference Call
The conference call will be webcast live at https://www.enpro.com, and by telephone at 1-877-407-0832, using the access code 13740583. The webcast and telephone line will open approximately 10 minutes before the call. Second quarter 2025 financial results and an accompanying slide presentation will be available on the company's website.
About Enpro
Enpro is a leading industrial technology company focused on critical applications across many end-markets, including semiconductor, industrial process, commercial vehicle, sustainable power generation, aerospace, food and pharma, photonics and life sciences. Headquartered in Charlotte, North Carolina, Enpro is listed on the New York Stock Exchange under the symbol 'NPO'. For more information, visit the company's website at https://www.enpro.com.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
5 minutes ago
- Business Wire
Western Alliance Bank Teams Up With FHLBank San Francisco to Award the Yavapai-Apache Nation $800,000 Grant
PHOENIX--(BUSINESS WIRE)-- Western Alliance Bank today announced, in collaboration with the Federal Home Loan Bank of San Francisco (FHLBank San Francisco), an $800,000 grant awarded to the Yavapai-Apache Nation to support capacity building for affordable housing development. Western Alliance Bank Teams Up With FHLBank San Francisco to Award the Yavapai-Apache Nation $800,000 Grant This grant funding will support Yavapai-Apache Nation Tribal Housing (YANTH)'s construction of Yavapai-Apache Homes IX. This 38-unit new construction project offers a mix of two-bedroom duplexes and three- and four-bedroom single-family homes on Tribal trust land in the Tunlii community on the Yavapai-Apache Reservation in Camp Verde, Arizona. 'Western Alliance Bank recognizes that it is essential for Tribal members to have a safe, affordable place to call home,' said Aidan Tracey, assistant vice president of portfolio management for Western Alliance Bank's Affordable Housing Investments Group. 'There is strong demand for quality, affordable housing for members of the Yavapai-Apache Nation. We are proud to play a role in securing the well-being and stability of these communities with this step toward addressing housing needs for the Nation.' In this phase of the project, 14 units are designated for households with annual incomes up to 30% of Area Median Income (AMI), 11 units for households with annual incomes up to 50% AMI, five units for households with annual incomes up to 60% AMI, and eight units for households up to 80% AMI. The Project also includes a community center for resident use. All of the units are committed for eventual tenant ownership at the end of the 15-year Low-Income Housing Tax Credit (LIHTC) compliance period. As a member bank of the FHLBank San Francisco, Western Alliance Bank sponsored the Yavapai-Apache Nation's application to help secure this much-needed funding. Acting in a fiduciary capacity, the Western Alliance Affordable Housing Investments Group supported the Nation by facilitating the disbursement of funds, ensuring compliance with program requirements. The grant was made possible through voluntary funding from FHLBank San Francisco, which supports affordable housing and economic development in local communities across Arizona, California and Nevada. Western Alliance Bank remains committed to building strong local partnerships that support affordable housing, economic development and financial empowerment in our communities. About Western Alliance Bank With more than $85 billion in assets, Western Alliance Bancorporation is one of the country's top-performing banking companies. Its primary subsidiary, Western Alliance Bank, Member FDIC, offers a full spectrum of tailored commercial banking solutions and consumer products, all delivered with outstanding service by banking and mortgage experts who put customers first. Major accolades include being ranked as a top U.S. bank in 2024 by American Banker and Bank Director and receiving #1 rankings on Extel's (formerly Institutional Investor's) All-America Executive Team Midcap Banks 2024 for Best CEO, Best CFO and Best Company Board of Directors. Serving clients across the country wherever business happens, Western Alliance Bank operates individual, full-service banking and financial brands with offices in key markets nationwide. For more information, visit Western Alliance Bank. About FHLBank San Francisco The Federal Home Loan Bank of San Francisco is a member-driven cooperative helping local lenders in Arizona, California, and Nevada build strong communities, create opportunity, and change lives for the better. The tools and resources we provide to our member financial institutions — commercial banks, credit unions, industrial loan companies, savings institutions, insurance companies, and community development financial institutions — propel homeownership, finance quality affordable housing, drive economic vitality, and revitalize whole neighborhoods. Together with our members and other partners, we are making the communities we serve more vibrant and resilient. About the Yavapai-Apache Nation The Yavapai-Apache Nation is a federally recognized tribal government located in the Verde Valley of central Arizona, encompassing five tribal communities: Tunlii, Middle Verde, Rimrock, Camp Verde and Clarkdale. With approximately 2,600 enrolled members, the Nation is committed to strengthening the well-being of its people through investments in housing, healthcare, education and cultural preservation.
Business Wire
5 minutes ago
- Business Wire
New Study Finds America's Largest Wealth Transfer Faces Unexpected Obstacle: The Family Dinner Table
ADA, Okla.--(BUSINESS WIRE)--The largest private asset transfer in history is facing a significant hurdle, as a new LegalShield study reveals nearly half of Baby Boomers (41%) and Gen Xers (45%) do not have basic estate planning documents like a will. This lack of planning by older generations leaves their Millennial and Gen Z heirs with significant and possibly costly uncertainty as a historic $84 trillion wealth transfer builds momentum expected to carry beyond 2045. This lack of planning also sets the stage for something most Millennials dread: family conflict. "The greatest risk to this $84 trillion wealth transfer isn't taxes – it's silence," said Warren Schlichting, LegalShield CEO. "An estate plan is essential, combined with open dialogue. Without planning and conversation, Americans risk trading family fortune for family feuds." The LegalShield survey of over 1,000 U.S. adults, conducted in June 2025, underscores the high stakes of this transfer, revealing that a clear majority of the next generation—including 63% of Millennials—is already counting on an inheritance. The Single Biggest Issue? Silence Even when estate plans exist, the study found a wall of silence can be just as damaging as having no plan at all. Nearly one in five (19%) Boomers and Gen Xers admit their family doesn't even know if they have a will. The silence is mutual: 42% of Millennials and Gen Zers expecting an inheritance have not discussed it with the person leaving it to them. A key result is anxiety: The top inheritance-related fear for Millennials is emotional, not financial. 58% of Millennials fear family conflict more than financial fears such as taxes. The Compounding Problem: Procrastination The study reveals a critical failure to plan among the generations holding the most wealth. 41% of Baby Boomers and 45% of Gen Xers—the two generations holding approximately 77% of U.S. private wealth according to the Federal Reserve—do not have a will. Among those with wills, many are dangerously out of date: 51% of Boomers and 46% of Gen Xers have not updated estate planning documents in more than three years. Gen X: Caught in the Middle The pressure is especially high for Gen Xers, who are caught in the unique position of expecting to inherit from their parents while also planning to leave wealth to their children. This "sandwich generation" role fuels their financial anxiety. One more dimension adds to the unease: 78% of Gen Xers report uncertainty about the economy, making them more concerned about protecting their assets. 'The silence between generations jeopardizes far more than just financial assets,' said Wayne Hassay, a LegalShield provider attorney. 'People think estate planning is only about who gets the house, but it's much more. It protects your kids, directs healthcare decisions, and handles digital assets. An attorney helps ensure no piece is missed, preventing a legal nightmare for your loved ones later on.' Study Methodology: The LegalShield survey was conducted in June 2025 among 1,018 U.S. adults. The data was segmented by generation (Gen Z, Millennials, Gen Xers, Baby Boomers) to analyze attitudes and behaviors toward estate planning and the generational wealth transfer. About LegalShield: For more than 50 years, LegalShield has provided everyday Americans with easy and affordable access to legal advice, counsel, protection, and representation. Serving millions, LegalShield is one of the world's largest platforms for legal, identity, and reputation management services protecting individuals and businesses across North America. Founded in 1972, LegalShield, and its privacy management product, IDShield, has provided individuals, families, businesses, and employers with tools and services needed to affordably live a just and secure life. Through technology and innovation, LegalShield is disrupting the traditional legal system and transforming how and where people receive legal guidance and services, with access to hundreds of qualified, trusted attorneys and law firms. LegalShield and IDShield are products of Pre-Paid Legal Services, Inc. To learn more about LegalShield and IDShield, visit and
Yahoo
21 minutes ago
- Yahoo
Genethon to Launch Pivotal Trial in Europe of GNT0004 a Low-Dose Microdystrophin Gene Therapy for Duchenne Muscular Dystrophy
Phase 3 trial clearance is based on the Phase 1/2 results demonstrating safety and efficacy of the 3x10¹³ vg/kg dose of microdystrophin, which is lower than doses used in other gene therapies for Duchenne muscular dystrophy (DMD). The double blind trial will be initiated in the UK and France beginning in August and September, and will enroll 64 boys aged 6 to 10 with DMD who have retained their walking ability. PARIS, July 28, 2025--(BUSINESS WIRE)--Genethon, a worldwide pioneer and leader in research and development in gene therapy for rare genetic diseases, has received approvals from regulatory authorities, MHRA and EMA*, to begin pivotal Phase 3 clinical trials in France and the UK of its gene therapy, GNT0004, for Duchenne muscular dystrophy (DMD). Genethon CEO Frederic Revah observed, "We are delighted to be able to continue these trials and are determined to bring GNT0004 to market for young patients and their families who are waiting for a therapeutic solution. This marks a decisive step forward for our gene therapy program for DMD, which began in 2021 and has demonstrated extremely promising results in the first children treated in the Phase1/2 portion of our Phase1/2/3 study." Dr. Revah added, "In addition to the very positive results in patients treated in the early phases, one of the strengths of our product is the dose selected for the pivotal phase, which is lower than those used in other gene therapy trials for DMD. Approvals of our Phase 3 trials reflect the regulatory authorities' confidence in GNT0004 as well as the work accomplished by our teams." The Phase 3 authorizations in Europe are based on the results of Phase 1/2 studies showing good tolerance of GNT0004 as well as efficacy in terms of microdystrophin expression, creatine phosphokinase (CPK) reduction, and motor function. Patients showed prolonged improvement or stabilization of motor functions and significant persistent reduction in CPK, a key marker of muscle damage. The Phase 3 double blind trials will begin in August and September in the UK and France using a single intravenous injection of GNT0004, which contains an optimized hMD1 transgene, a shortened (3x10¹³ vg/kg microdystrophin) but functional version of the gene encoding dystrophin in an AAV8 vector associated with transient immunological prophylactic treatment. The vector is designed to express itself in muscle tissue and the heart thanks to a Spc5-12 promoter sequence specific to these tissues. A total of 64 boys aged 6 to 10 with DMD who have retained their walking ability will be enrolled. * French ANSM as reporting member state for the EMA About Duchenne muscular dystrophy Duchenne muscular dystrophy is a rare progressive genetic disease that affects all the muscles in the body and mainly boys (1 in 5,000). It is caused by abnormalities in the gene responsible for the production of dystrophin, a structural protein essential for the stability of muscle fiber membranes and their metabolism. The absence of dystrophin leads to progressive degeneration of the skeletal and cardiac muscles, loss of walking and respiratory capacity, progressive heart failure, and death between the ages of 20 and 40. About Genethon A pioneer in the discovery and development of gene therapies for rare diseases, Genethon is a non-profit laboratory created by the AFM-Telethon. A first gene therapy drug, to which Genethon contributed, has been approved for marketing for spinal muscular atrophy. With more than 240 scientists and experts, Genethon's goal is to develop innovative therapies that change the lives of patients suffering from rare genetic diseases. Thirteen gene therapy products developed by Genethon or to which Genethon has contributed are currently undergoing clinical trials for diseases of the liver, blood, immune system, muscles, and eyes. Seven other products are in preparation for clinical trials over the next five years. View source version on Contacts Press contact:Marion Delbouis/Stéphanie Bardon – communication@ / +33 (0)6 45 15 95 87 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
